Evaluate of Tolterodine for lower urinary tract syndrome after prostate Brachytherapy
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000004843
- Lead Sponsor
- Keio University Shool of Medicine Department of Urology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 32
Not provided
1. PVR>or=100cc 2. Patient with urinary tract infection 3. Patient of anti-cholinergic medicine administration taboo a. Patient with urinary retention b. Patient whose pylorus or duodenum or ileum are obstructed, or who has paralytic ileus c. Patient whose digestive organ movement or tention are decreased d. Patient with narrow-angle glaucoma e. Patient with myasthenia gravis f. Patient with severe heart disease g. Patient with sevre hepatic dysfunction (Child-Pugh classification C) h. Patient with hypersentivity for anti-cholinergic medicine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To verify change rate of Overactive Bladder symptom score(OABSS) after 8week
- Secondary Outcome Measures
Name Time Method